Description: Numares Health uses AI-enabled technology to develop novel diagnostics for conditions stemming from metabolic dysfunction, including chronic kidney, cardiovascular and liver diseases. Numares develops advanced tests for diagnosis and measurement of disease progression by applying machine learning to metabolomics, evaluating multiple biomarkers alone and in combination. The company developed the FDA-cleared AXINON® System that makes next-generation use of nuclear magnetic resonance spectroscopy for this biom
test (4462) system (3852) diagnostics (1110) laboratory (1100) precision (893) clinical (755) cardiovascular (252) mgs (107) metabolic (74) axinon (5)
Magnetic Group Signaling ( MGS ® ) standardizes NMR systems and sample processing to ensure reproducible results on different NMR instruments.
Learn more
Advanced. Automated. Affordable. Mastering Metabolite Constellations for Real-Time Precision Medicine.